Nan Fung Group Holdings Ltd
CIK: 1782539
Exit Positions
0
Holdings (25)
Q2 2026 13F, quarter ended Jun 30, 2026, filed Aug 13, 2026
- MPLT
MAPLIGHT THERAPEUTICS INC
$34.81M
971,253 sh26.47%+0.0% - LBRX
LB PHARMACEUTICALS INC
$20.47M
630,657 sh15.57%+0.0% - EVMN
EVOMMUNE INC
$19.15M
1.44M sh14.56%+0.0% - HELP
CYBIN INC
$6.53M
987,222 sh4.96%+114.6% - INCY
INCYTE CORP
$6.09M
53,742 sh4.63%+0.0% - RYTM
RHYTHM PHARMACEUTICALS INC
$5.45M
49,120 sh4.15%+0.0% - ONC
BEONE MEDICINES LTD
$4.48M
15,722 sh3.41%+0.0% - OCS
OCULIS HOLDING AG
$4.17M
300,565 sh3.17%-14.3% - ASND
ASCENDIS PHARMA A/S
$3.63M
13,600 sh2.76%+0.0% - RVMD
REVOLUTION MEDICINES INC
$3.61M
19,253 sh2.74%+0.0% - KYMR
KYMERA THERAPEUTICS INC
$3.54M
30,875 sh2.69%+0.0% - MDGL
MADRIGAL PHARMACEUTICALS INC
$3.05M
5,672 sh2.32%+0.0% - CELC
CELCUITY INC
$2.96M
28,300 sh2.25%+0.0% - ACAD
ACADIA PHARMACEUTICALS INC
$2.61M
102,984 sh1.98%+0.0% - ARGX
ARGENX SE
$2.6M
2,800 sh1.98%+0.0% - RXRX
RECURSION PHARMACEUTICALS IN
$2.18M
595,287 sh1.66%+0.0% - PCOR
PROCORE TECHNOLOGIES INC
$2.17M
53,299 sh1.65%+0.0% - HRMY
HARMONY BIOSCIENCES HLDGS IN
$985K
27,049 sh0.75%+0.0% - INSM
INSMED INC
$702K
6,580 sh0.53%+0.0% - ETHA
ISHARES ETHEREUM TR
$601K
50,549 sh0.46%+0.0% - IBIT
ISHARES BITCOIN TRUST ETF
$532K
15,968 sh0.40%+0.0% - CHYM
CHIME FINL INC
$432K
21,075 sh0.33%New - RANI
RANI THERAPEUTICS HLDGS INC
$375K
493,584 sh0.29%+0.0% - TRDA
ENTRADA THERAPEUTICS INC
$361K
49,082 sh0.27%+0.0% - BOLT
BOLT BIOTHERAPEUTICS INC
$19K
5,000 sh0.01%-82.9%
| Security | Shares | Value | Change | Weight | Period |
|---|---|---|---|---|---|
 MPLT MAPLIGHT THERAPEUTICS INC | 971,253 | $34.81M | +0.0% | 26.47% | Q2 2026 |
 LBRX LB PHARMACEUTICALS INC | 630,657 | $20.47M | +0.0% | 15.57% | Q2 2026 |
 EVMN EVOMMUNE INC | 1.44M | $19.15M | +0.0% | 14.56% | Q2 2026 |
 HELP CYBIN INC | 987,222 | $6.53M | +114.6% | 4.96% | Q2 2026 |
 INCY INCYTE CORP | 53,742 | $6.09M | +0.0% | 4.63% | Q2 2026 |
 RYTM RHYTHM PHARMACEUTICALS INC | 49,120 | $5.45M | +0.0% | 4.15% | Q2 2026 |
 ONC BEONE MEDICINES LTD | 15,722 | $4.48M | +0.0% | 3.41% | Q2 2026 |
 OCS OCULIS HOLDING AG | 300,565 | $4.17M | -14.3% | 3.17% | Q2 2026 |
 ASND ASCENDIS PHARMA A/S | 13,600 | $3.63M | +0.0% | 2.76% | Q2 2026 |
 RVMD REVOLUTION MEDICINES INC | 19,253 | $3.61M | +0.0% | 2.74% | Q2 2026 |
 KYMR KYMERA THERAPEUTICS INC | 30,875 | $3.54M | +0.0% | 2.69% | Q2 2026 |
 MDGL MADRIGAL PHARMACEUTICALS INC | 5,672 | $3.05M | +0.0% | 2.32% | Q2 2026 |
 CELC CELCUITY INC | 28,300 | $2.96M | +0.0% | 2.25% | Q2 2026 |
 ACAD ACADIA PHARMACEUTICALS INC | 102,984 | $2.61M | +0.0% | 1.98% | Q2 2026 |
 ARGX ARGENX SE | 2,800 | $2.6M | +0.0% | 1.98% | Q2 2026 |
 RXRX RECURSION PHARMACEUTICALS IN | 595,287 | $2.18M | +0.0% | 1.66% | Q2 2026 |
 PCOR PROCORE TECHNOLOGIES INC | 53,299 | $2.17M | +0.0% | 1.65% | Q2 2026 |
 HRMY HARMONY BIOSCIENCES HLDGS IN | 27,049 | $985K | +0.0% | 0.75% | Q2 2026 |
 INSM INSMED INC | 6,580 | $702K | +0.0% | 0.53% | Q2 2026 |
 ETHA ISHARES ETHEREUM TR | 50,549 | $601K | +0.0% | 0.46% | Q2 2026 |
 IBIT ISHARES BITCOIN TRUST ETF | 15,968 | $532K | +0.0% | 0.40% | Q2 2026 |
 CHYM CHIME FINL INC | 21,075 | $432K | New | 0.33% | Q2 2026 |
 RANI RANI THERAPEUTICS HLDGS INC | 493,584 | $375K | +0.0% | 0.29% | Q2 2026 |
 TRDA ENTRADA THERAPEUTICS INC | 49,082 | $361K | +0.0% | 0.27% | Q2 2026 |
 BOLT BOLT BIOTHERAPEUTICS INC | 5,000 | $19K | -82.9% | 0.01% | Q2 2026 |
1-25 of 25 holdings
Sector Allocation
SEC Filings
| Form | Description | Filed |
|---|---|---|
About Nan Fung Group Holdings Ltd
Nan Fung Group Holdings Ltd is an Investment Adviser that reports its US-listed stock and option positions to the SEC on Form 13F (CIK 1782539). Signal8 holds 20 13F filings from it.
Its most recent 13F holdings report covers Q2 2026 (the quarter ended Jun 30, 2026) and was filed on Aug 13, 2026. That report lists 25 securities, not counting options, up from 24 in Q1 2026.
Its five largest reported positions, in order, are MAPLIGHT THERAPEUTICS INC (MPLT), LB PHARMACEUTICALS INC (LBRX), EVOMMUNE INC (EVMN), CYBIN INC (HELP) and INCYTE CORP (INCY). The next five are RHYTHM PHARMACEUTICALS INC (RYTM), BEONE MEDICINES LTD (ONC), OCULIS HOLDING AG (OCS), ASCENDIS PHARMA A/S (ASND) and REVOLUTION MEDICINES INC (RVMD).
Recent 13F filings by Nan Fung Group Holdings Ltd
- Q2 2026: 13F-HR filed Aug 13, 2026, listing 25 securities.
- Q1 2026: 13F-HR filed May 14, 2026, listing 24 securities.
- Q4 2025: 13F-HR filed Feb 13, 2026, listing 27 securities.
- Q3 2025: 13F-HR filed Nov 13, 2025, listing 24 securities.
- Q2 2025: 13F-HR filed Aug 13, 2025, listing 20 securities.
- Q1 2025: 13F-HR filed May 14, 2025, listing 35 securities.